4//SEC Filing
Lim Jonathan E 4
Accession 0001209191-23-057681
CIK 0001761918other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 7:41 PM ET
Size
8.2 KB
Accession
0001209191-23-057681
Insider Transaction Report
Form 4
Erasca, Inc.ERAS
Lim Jonathan E
DirectorChairman & CEO10% Owner
Transactions
- Purchase
Common Stock
2023-12-06$1.72/sh+278,150$478,418→ 12,899,360 total(indirect: By LLC) - Purchase
Common Stock
2023-12-05$1.69/sh+721,850$1,217,761→ 12,899,360 total(indirect: By LLC)
Holdings
- 19,456,216(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Includes purchases made on December 5, 2023, and December 6, 2023 that are reported on this Form 4.
- [F2]Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.
- [F3]The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
Documents
Issuer
Erasca, Inc.
CIK 0001761918
Entity typeother
Related Parties
1- filerCIK 0001283290
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 7:41 PM ET
- Size
- 8.2 KB